Author

P. Kozlowski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Philips· 1 shared A. Piekielko-Witkowska· 1 shared D. Nowis· 1 shared E. Kozlowska· 1 shared F. Hornung· 1 shared G. Hoser· 1 shared I. M.· 1 shared J. Golab· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Philips

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells

M. Abrozek-Latecka, P. Kozlowski, G. Hoser, M. Bandyszewska, K. Hanusek, D. Nowis, J. Golab, M. Grzanka, A. Piekielko-Witkowska, L. Schulz, F. Hornung, S. Deinhardt-Emmer, E. Kozlowska, T. Skirecki

This study shows SARS-CoV-2 viroporins ORF3a, E, and M activate inflammasomes in macrophages and induce IL-1α release in pulmonary epithelial and endothelial cells, contributing to immunothrombosis in COVID-19.

bioRxiv · Nov 13, 2023 · PreprintImmunology

Profile of basal cell carcinoma mutations and copy number alterations - focus on gene-associated noncoding variants

P. M. Nawrocka, P. Galka-Marciniak, M. O. Urbanek-Trzeciak, I. M., N. Szostak, A. Philips, L. Susok, M. Sand, P. Kozlowski

This study analyzes coding and noncoding mutations in basal cell carcinoma, finding that noncoding variants account for ~50% of mutations and identify new cancer drivers.

bioRxiv · Jun 24, 2021Cancer Biology